Astec LifeSciences Limited reported earnings results for the second quarter and six months ended September 30, 2023. For the second quarter, the company reported sales was INR 1,107.89 million compared to INR 1,997.47 million a year ago. Revenue was INR 1,117.68 million compared to INR 2,037.33 million a year ago. Net loss was INR 134.27 million compared to net income of INR 183.08 million a year ago. Basic loss per share from continuing operations was INR 6.85 compared to basic earnings per share from continuing operations of INR 9.34 a year ago. Diluted loss per share from continuing operations was INR 6.85 compared to diluted earnings per share from continuing operations of INR 9.34 a year ago.
For the six months, sales was INR 2,536.38 million compared to INR 3,840.13 million a year ago. Revenue was INR 2,563.25 million compared to INR 3,907.1 million a year ago. Net loss was INR 216.22 million compared to net income of INR 297.08 million a year ago. Basic loss per share from continuing operations was INR 11.03 compared to basic earnings per share from continuing operations of INR 15.16 a year ago. Diluted loss per share from continuing operations was INR 11.03 compared to diluted earnings per share from continuing operations of INR 15.15 a year ago.